PCN133 - THE SOCIETAL IMPACT OF OBINUTUZUMAB IN THE FIRST LINE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA IN GERMANY
Abstract
Authors
S. Hofmann D.A. Ostwald S. Himmler A. Launonen U. Dünzinger H. Salmen
S. Hofmann D.A. Ostwald S. Himmler A. Launonen U. Dünzinger H. Salmen
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now